United States · 
Who invested in Isis Pharmaceuticals?
Isis Pharmaceuticals's investors include GlaxoSmithKline.
20132014
$201MDebt$11MVentureUnited States · Venture startup
Who invested in Isis Pharmaceuticals
2 rounds we have observed, with the one investor named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$212Mraised across 2 rounds since 2012, from 2 sources
$201MDebt$11MVenture
- Latest round
- Venture, $11MJul 2014
- Biggest round
- $201MDebt · Aug 2012
- Investors
- 1
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Debt, $201M Aug 2012
- Biggest round
- $201M Debt · Aug 2012
- Between rounds
- 22 months from the last two
The rounds
- Jul 2014
- Aug 2012Debt$201M
No investor was named in the report.
Reported by sec.govSEC filing: $201M sold, first sale Aug 2012
The exit
ExitListingPriceWhen
IPONASDAQ:ISISundisclosedMay 1991
From historical deal records. Wrong? Tell us.
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Isis Pharmaceuticals
How much has Isis Pharmaceuticals raised?
Isis Pharmaceuticals has raised $212M across 2 rounds since 2012.
When did Isis Pharmaceuticals last raise?
Isis Pharmaceuticals's most recent round was a Venture of $11M in Jul 2014.
What was Isis Pharmaceuticals's biggest round?
Isis Pharmaceuticals's largest round on record is $201M (Debt), in Aug 2012.
Who backed Isis Pharmaceuticals first?
Isis Pharmaceuticals's first round on record, in Jul 2014, was backed by GlaxoSmithKline.
What stage is Isis Pharmaceuticals at?
Isis Pharmaceuticals's latest named round is a Venture, in Jul 2014.
Where is Isis Pharmaceuticals based?
Isis Pharmaceuticals is based in the United States.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.